APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility
Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom

Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy
APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility
LPS-evoked IL-18 expression in mesangial cells plays a role in accelerating lupus nephritis
Association between SLE nephritis and polymorphic variants of the CRP and FcRIIIa genes

Ultrasonography is a sensitive tool for monitoring localized scleroderma
Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom
The cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in the UK
Predicting adverse outcomes in primary Sjögren\'s syndrome: identification of prognostic factors

Predicting autoimmune congenital heart block: is it feasible and how?
Emerging biological therapies in primary Sjögren\'s syndrome